What specific commitments did CVS Caremark make in its settlement with the FTC regarding TrumpRx purchases and insurance deductibles?

CVS Caremark agreed to count consumers' out-of-pocket payments made through the TrumpRx.gov website toward their health insurance deductibles, once regulations are in place to support the TrumpRx program. This means that cash-pay purchases of drugs—including discounted weight-loss medications from Eli Lilly and Novo Nordisk—made via TrumpRx will now contribute to meeting deductible requirements under certain CVS-administered health plans.

How does the CVS-FTC settlement address pharmacy benefit manager (PBM) rebate practices, and what new option must CVS provide to its clients?

The settlement requires CVS Caremark to curb its use of after-market drugmaker rebates—a practice critics say inflates drug prices—and to offer clients an opt-out option from rebate-based payment models. These rebates, paid by drugmakers to the PBM, are not guaranteed to be passed on to plan sponsors or consumers, and the new provision gives health plan clients the ability to choose alternative pricing arrangements.

CVS Settles with FTC to Include TrumpRx Purchases in Insurance Deductibles

Jul 14, 2026

CVS Health's Caremark settled with the FTC to curb rebate practices and count TrumpRx purchases toward deductibles. The deal targets billions in drug price savings and addresses anticompetitive behavior.

reuters

2026-05-06

CVS Health raises 2026 forecast after improving medical cost controls

2026-07-14

CVS Settles with FTC to Include TrumpRx Purchases in Insurance Deductibles

2026-08-05

CVS Raises Annual Profit Forecast on Improved Drug Revenues

CVS Settles with FTC to Include TrumpRx Purchases in Insurance Deductibles

FAQ